Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Allison M. Winter, Olivia Landever, Hiruni Mendries, Willem Van Heeckeren, Chieh-Lin Fu, Robert M. Dean, Taylor R. Brooks, Deepa Jagadeesh, Paolo F. Caimi, Brian T. Hill

Blood (2024) 144 (Supplement 1): 3247.

https://doi.org/10.1182/blood-2024-200306

Published: 2024

Journal Articles

Epidemiological Trends in Incidence, Death and Associated Risk Factors of Multiple Myeloma 1990-2021 and Projection to 2040

Rupayan Kundu, Niladri Kal, Abhay Singh, Louis Williams, Jack Khouri, Christy J. Samaras, Jason Valent, Shahzad Raza, Willem Van Heeckeren, Faiz Anwer, Sandra Mazzoni

Blood (2024) 144 (Supplement 1): 1969.

https://doi.org/10.1182/blood-2024-211861

Published: 2024

Journal Articles

Assessing the Efficacy and Safety of Reduced Dexamethasone Duration in Newly Diagnosed AL Amyloidosis Versus Standard Therapy

John Hanna, Ryan Brown, Zain Ali Burney, Kawther Abdallah, Jason Valent, Christy J. Samaras, Faiz Anwer, Jack Khouri, Louis Williams, Shahzad Raza, Willem Van Heeckeren, Sandra Mazzoni

Blood (2024) 144 (Supplement 1): 1911.

https://doi.org/10.1182/blood-2024-208479

Published: 2024

Journal Articles

Contemporary Use of VTD-PACE As Bridge Therapy in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma

Heena P Kurish, Kerri Row, Austin Kurkowski, Mikhaila Rice, Joslyn Rudoni, Jack Khouri, Sandra Mazzoni, Christy J. Samaras, Louis S. Williams, Willem van Heeckeren, Jason Valent, Faiz Anwer

Blood (2022) 140 (Supplement 1): 12496–12497.

https://doi.org/10.1182/blood-2022-162821

Published: 2022